1-(2-氨基乙基)脲 | 2035-78-1

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 有机碳酸及其衍生物
• 中文名称: 1-(2-氨基乙基)脲
• 英文名称: (2-amino-ethyl)-urea
• 英文别名: (2-Amino-aethyl)-harnstoff；1-(2-aminoethyl)urea；N-(2-aminoethyl)urea；2-Aminoethylurea
• CAS: 2035-78-1
• 化学式: C₃H₉N₃O
• mdl: MFCD08060138
• 分子量: 103.124
• InChiKey: ZULYWHOJRVBUJU-UHFFFAOYSA-N

物化性质

• 沸点：
  224.8±32.0 °C(Predicted)
• 密度：
  1.128±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -2
• 重原子数：
  7
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.666
• 拓扑面积：
  81.1
• 氢给体数：
  3
• 氢受体数：
  2

安全信息

• 海关编码：
  2924199090

反应信息

• 作为反应物：
  描述：

  1-(2-氨基乙基)脲 、 苯基缩水甘油醚 在 sodium hydroxide 作用下， 以 丙醇 为溶剂， 反应 18.0h， 以10%的产率得到2-[(2-Hydroxy-3-phenoxypropyl)amino]ethylurea
  参考文献：
  名称：

  .beta.-Adrenergic blocking agents. 22. 1-Phenoxy-3-[[(substituted-amido)alkyl]amino]-2-propanols

  摘要：

  The synthesis of a series of 1-phenoxy-3-[[(substituted-amido)alkyl]amino]-2-propanols is described. Many of the compounds are more potent than propanolol as beta blockers, while having cardioselectivity comparable to that of practolol, when given intravenously to anesthetized cats. The structure-activity relationships shown by this series of compounds provide further evidence that the addition of substituents to the alkylamino moeity of a beta blocker can confer cardioselectivity and that amidic substituents are remarkably effective.

  DOI：

  10.1021/jm00353a004
• 作为产物：
  描述：

  potassium cyanate 、 乙二胺 在 盐酸 作用下， 生成 1-(2-氨基乙基)脲
  参考文献：
  名称：

  DE476533

  摘要：

  公开号：

文献信息

• 4-(4-CYANO-2-THIOARYL)DIHYDROPYRIMIDINONES AND THEIR USE
  申请人：Von Nussbaum Franz

  公开号：US20110034433A1

  公开（公告）日：2011-02-10

  The present invention relates to novel 4-(4-cyano-2-thioaryl)dihydropyrimidin-2-one derivatives, to processes for their preparation, to their use alone or in combination for the treatment and/or prevention of diseases and also to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of disorders of the lung and the cardiovascular system.

  本发明涉及新颖的4-(4-氰基-2-硫代芳基)二氢嘧啶-2-酮衍生物，涉及它们的制备方法，以及它们单独或与其他药物结合用于治疗和/或预防疾病，还涉及它们用于制备用于治疗和/或预防疾病的药物，特别是用于治疗和/或预防肺部和心血管系统疾病的用途。
• Aminopyridine carboxamides as c-Jun N-terminal kinase inhibitors: Targeting the gatekeeper residue and beyond
  作者：Gang Liu、Hongyu Zhao、Bo Liu、Zhili Xin、Mei Liu、Christi Kosogof、Bruce G. Szczepankiewicz、Sanyi Wang、Jill E. Clampit、Rebecca J. Gum、Deanna L. Haasch、James M. Trevillyan、Hing L. Sham

  DOI：10.1016/j.bmcl.2006.08.097

  日期：2006.11

  The structure-activity relationships of 5,6-positions of aminopyridine carboxamide-based c-Jun N-terminal Kinase (JNK) inhibitors were explored to expand interaction with the kinase specificity and ribose-binding pockets. The syntheses of analogues and the impact of structural modification on in vitro potency and cellular activity are described. (c) 2006 Elsevier Ltd. All rights reserved.
• CH605666
  申请人：——

  公开号：——

  公开（公告）日：——
• .beta.-Adrenergic blocking agents. 23. 1-(Substituted-amido)phenoxy-3-[[(substituted-amido)alkyl]amino]propan-2-ols
  作者：M. S. Large、L. H. Smith

  DOI：10.1021/jm00357a008

  日期：1983.3

  The synthesis of a series of 1-phenoxy-3-[(amidoalkyl)amino]propan-2-ols, in which the phenoxy ring is variously substituted with ortho and para amidic moieties, is described. Several of the compounds have beta-blocking potency comparable to that of propranolol and cardioselectivity similar to that of practolol, when given intravenously to anesthetized cats. In contrast to previous findings with cardioselective beta blockers, both ortho and para substitution give variable degrees of cardioselectivity. Potency, however, is favored by ortho substitution.
• CH614925
  申请人：——

  公开号：——

  公开（公告）日：——